Silicon Kidney
San Francisco, CA · Medtech · Private
Silicon nanopore membrane-based bioartificial pancreas device with encapsulated islets for Type 1 diabetes treatment
- Grants
- $7.1M
- 11 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · An intravascular Bioartificial Pancreas (iBAP) | $746,324 | |
| Federal grant | Department of Health and Human Services · Phase II · An implantable hemodialyzer for treatment of End-stage Renal Disease | $756,920 | |
| Federal grant | Department of Health and Human Services · Phase II · An intravascular Bioartificial Pancreas (iBAP) | $746,229 | |
| Federal grant | Department of Health and Human Services · Phase II · An implantable hemodialyzer for treatment of End-stage Renal Disease | $738,210 | |
| Federal grant· 1 of 3 same day | Department of Health and Human Services · Phase I · A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | $224,189 | |
| Federal grant· 2 of 3 same day | Department of Health and Human Services · Phase I · A high oxygen capacity cell scaffold for the intravascular bioartifical pancreas (iBAP) | $298,388 | |
| Federal grant· 3 of 3 same day | Department of Health and Human Services · Phase I · A high oxygen capacity cell scaffold for the intravascular bioartifical pancreas (iBAP) | $298,388 | |
| Federal grant | Department of Health and Human Services · Phase II · A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | $1,019,979 | |
| Federal grant | Department of Health and Human Services · Phase II · A silicon nanopore membrane blood filter enabling anticoagulant free continuous renal replacement therapy for acute kidney injury | $1,019,958 | |
| Federal grant | Department of Health and Human Services · Phase I · The intracorporeal hemodialysis system (iHemo) for eliminating the mortality health disparity of rural and remote End-stage Kidney Disease patients | $256,501 | |
| Federal grant | Department of Health and Human Services · Phase II · An intravascular Bioartificial Pancreas (iBAP) | $1,000,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1866 | Critical Link, LLC | — | — |
| 1867 | Qualia, Inc. | — | — |
| 1868 | Minnetronix Medical, Inc. | — | — |
| 1869 | Silicon Kidney | — | — |
| 1870 | FISTULA SOLUTION CORPORATION | — | — |
| 1871 | LifeWave, Inc. | — | $618K |
| 1872 | Narnar, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.